Shortness of Breath Climbing Stairs. A Cardiologist's Triage Guide.

The man files it under deconditioning. He used to run. He has not run in a year. He is carrying a few more pounds. Of course he gets winded on stairs now. He will start running again when things calm down. In the meantime, he avoids the stairs. What he has not stopped to consider is this: deconditioning does not explain why he was managing three flights without a second thought six months ago and cannot get through one now.

The Mechanism

To understand why shortness of breath climbing stairs matters, you need to understand what the body is doing during exertion and what must go right for it to go unnoticed.

At rest, the adult heart pumps roughly five liters of blood per minute. During brisk stair climbing, that demand can rise to fifteen or twenty liters per minute in a fit individual. The heart achieves this increase through two mechanisms working in parallel. First, sympathetic nervous system activation raises the heart rate and increases the force of each contraction. Second, the Frank-Starling mechanism responds to increased venous return by stretching the ventricle, which allows a more forceful ejection with each beat. Stroke volume rises. Heart rate rises. Peripheral blood vessels in working muscle dilate to accept the increased flow. Oxygen extraction at the tissue level increases. The entire system scales upward smoothly, and in a healthy person with reasonable fitness, this scaling is unconscious.

When the system scales poorly, breathlessness is the result. The specific cause determines where the breakdown occurs.

Coronary artery disease. Significant stenosis in a coronary artery creates a perfusion mismatch during exertion. At rest, even a 70 percent stenosis may allow adequate flow. When demand rises during stair climbing, the narrowed artery cannot deliver enough blood to the myocardium it supplies. The ischemic cascade proceeds in a predictable sequence: diastolic dysfunction appears first, then systolic dysfunction, then electrocardiographic changes, and finally symptoms. Breathlessness, not chest pain, is the presenting symptom in a meaningful proportion of men with coronary disease, particularly those who have developed a high pain threshold or who attribute discomfort to musculoskeletal causes.

Heart failure with preserved ejection fraction (HFpEF). This is the form of heart failure most likely to be missed, and most likely to affect the middle-aged man with hypertension, obesity, or type 2 diabetes. In HFpEF, the left ventricle stiffens over time. At rest, the ejection fraction looks normal, which is why the condition is frequently labeled “not heart failure” at initial evaluation. During exertion, the stiff ventricle cannot fill rapidly enough to meet increased demand. Left atrial pressure rises. Pulmonary venous pressure rises. The result is exertional breathlessness with a structurally “normal-looking” heart on a resting echocardiogram.

Heart failure with reduced ejection fraction (HFrEF). In HFrEF, the heart’s pumping capacity is directly impaired. Stroke volume is fixed and low. The heart compensates at rest through elevated heart rate and neurohormonal mechanisms, but during exertion, the reserve is simply not there. Cardiac output cannot rise to meet demand. The symptom is breathlessness, fatigue, or both.

Pulmonary causes. Obstructive lung disease, including COPD and asthma, restricts airflow during the increased ventilatory demand of exertion. Restrictive lung disease reduces the total volume available for gas exchange. Pulmonary arterial hypertension raises the pressure in the pulmonary vasculature, which the right ventricle must overcome, and can produce breathlessness that is easily mistaken for cardiac or deconditioning-related causes.

Anemia. When red cell mass is reduced, each liter of blood carries less oxygen. The body compensates by increasing cardiac output at rest and exaggerating that increase during activity. The heart rate rises disproportionately with minimal exertion. Breathlessness climbing stairs can be the first reported symptom of significant anemia, particularly iron-deficiency anemia in men who are not routinely screened.

Deconditioning. This is a real physiological state. A sedentary man has reduced skeletal muscle oxidative capacity, a lower peak cardiac output, and a higher resting heart rate relative to a trained peer. He will get winded on stairs. But deconditioning has a specific pattern: the threshold is stable. Two flights produce breathlessness today, two flights produce the same breathlessness three months from now. The deconditioned man is not worsening. If the threshold is falling, deconditioning alone does not explain it.

The trajectory is the key clinical signal. A man who was managing three flights six months ago and is now struggling with one is not simply deconditioned. Something has changed, and clinical evaluation is the only way to determine what.

What the Evidence Shows

The data on exertional dyspnea as a cardiac signal is not speculative. Several well-designed studies define the landscape clearly enough to inform clinical decisions, even if they are largely observational rather than interventional.

Owan et al., writing in the New England Journal of Medicine in 2006, analyzed trends in heart failure hospitalizations at Olmsted County from 1987 to 2001 and found that the proportion of heart failure cases with preserved ejection fraction rose from 38 percent to 54 percent over that period. HFpEF had become the dominant form of heart failure in the community. The relevance for exertional dyspnea is direct: most HFpEF is missed until it is advanced, because resting tests look reassuringly normal.

Redfield et al., in JAMA in 2003, used echocardiographic data from the Olmsted County population to estimate the prevalence of diastolic dysfunction. They found that 28 percent of the general population had some degree of diastolic dysfunction, and that most of those individuals did not carry a heart failure diagnosis. The condition was subclinical in the majority of cases. These are people with stiffened ventricles who may be experiencing exertional symptoms without knowing their cardiac function is abnormal.

For coronary artery disease, the ISCHEMIA trial, published in the New England Journal of Medicine in 2020, enrolled more than 5,000 patients with moderate or severe ischemia on stress testing. A substantial proportion of these patients presented with stable exertional symptoms rather than acute events. The trial’s finding that guideline-directed medical therapy performed comparably to revascularization in many stable patients does not reduce the importance of diagnosis; it reinforces that men with exertional ischemia need to be identified and treated, by one method or another.

Data from ACC/AHA guideline documents on stable ischemic heart disease note that dyspnea on exertion, distinct from classic angina, is a common anginal equivalent in women and is underappreciated in men as well. Men with significant coronary disease not infrequently present to stress testing with breathlessness as the primary complaint.

For pulmonary disease, the underdiagnosis literature is equally sobering. Lamprecht et al., in the Lancet in 2011, using data from the Burden of Obstructive Lung Disease (BOLD) study across twelve countries, estimated that the majority of patients with spirometry-confirmed COPD had not received a diagnosis. These are people attributing their breathlessness to aging, weight, or fitness, while the underlying obstructive physiology goes uncharacterized.

The diagnostic yield of exercise stress testing in new exertional dyspnea without a prior cardiac diagnosis is clinically meaningful. A meta-analysis by Metz and Grayburn (reviewing exercise echocardiography literature) found that in patients with unexplained dyspnea, stress echocardiography identified previously undiagnosed cardiac pathology in a significant proportion of cases, including occult coronary disease and HFpEF made apparent by exertional elevation in filling pressures.

A note on the evidence rating: most of this data is observational, epidemiological, or derived from guideline consensus rather than randomized controlled trials with exertional dyspnea as the primary endpoint. The evidence is strong enough to guide clinical triage and clearly establishes the importance of not presuming a benign cause. It is not strong enough to support highly specific probability claims for individual cases. Clinical evaluation remains essential.

NT-proBNP and BNP: The Blood Test That Separates Cardiac From Non-Cardiac Breathlessness

When a man arrives at a physician’s office with new exertional breathlessness, the differential diagnosis spans ischemic disease, heart failure, pulmonary disease, anemia, and deconditioning. Clinical history and physical examination narrow the field but rarely produce a definitive answer before imaging and functional testing are complete. Natriuretic peptides provide a simple blood test that adjusts the probability of cardiac versus non-cardiac causes and can orient the investigative sequence.

Brain natriuretic peptide (BNP) and its precursor N-terminal pro-BNP (NT-proBNP) are released by ventricular cardiomyocytes in response to elevated wall stress from pressure overload, volume overload, or ischemic dysfunction. In the absence of cardiac dysfunction, myocardial wall stress is low and natriuretic peptide levels remain low. When the left ventricle operates under elevated filling pressures — from heart failure, significant ischemia, or severe hypertrophic disease — secretion increases in direct proportion to the degree of stress.

Maisel and colleagues, reporting the Breathing Not Properly study in the New England Journal of Medicine in 2002, enrolled 1,586 patients presenting to the emergency department with acute dyspnea and evaluated the diagnostic performance of BNP. A BNP cut-point of 100 pg/mL had a sensitivity of 90 percent and specificity of 76 percent for heart failure as the cause of dyspnea, with an area under the ROC curve of 0.91. The diagnostic accuracy of BNP exceeded the accuracy of clinical judgment alone and rivaled echocardiography for identifying the cardiac contribution to the presentation. 5 / Solid

For outpatient evaluation of stable exertional dyspnea rather than an acute presentation, the calibration differs but the principle holds. An elevated BNP or NT-proBNP in a man with new exertional breathlessness supports cardiac pathology as the primary cause and directs the investigative pathway toward echocardiography and stress testing before pulmonary function testing. A normal natriuretic peptide level makes heart failure less likely, though it does not exclude coronary ischemia without elevated filling pressures or early HFpEF with compensated hemodynamics.

Two caveats apply specifically to middle-aged men. First, obesity reduces circulating BNP levels through adipose tissue clearance of the peptide, creating the paradox that the patients most likely to have HFpEF — those who are obese, hypertensive, and diabetic — may have falsely reassuring BNP values relative to the actual degree of cardiac dysfunction. Second, atrial fibrillation elevates BNP independently of ventricular dysfunction, requiring clinical context to interpret an elevated result in a man who is also in AF.

For the man and his physician navigating a new exertional dyspnea complaint before stress testing is scheduled, adding BNP or NT-proBNP to the initial blood draw costs very little and orients the diagnostic sequence more efficiently than a purely clinical triage approach.

What to Do This Week

1. Keep a symptom diary for seven consecutive days. For each episode of breathlessness on stairs or with exertion, record the specifics: how many flights, the pace, whether you were carrying anything, the time of day, the temperature, and how long it took for your breathing to return to baseline. Note any associated symptoms: chest pressure, tightness, palpitations, or lightheadedness. This is the data your physician needs to triage appropriately. A vague report of “getting winded” is far less useful than “two flights at a moderate pace, recovery in four minutes, no chest discomfort, happened three times this week.”

2. Establish your personal trajectory in writing. Before your appointment, write down the answer to this question: What could you do six months ago, and one year ago, that you cannot do now at the same exertion level? Be specific. If you walked a certain route without breathlessness and you now cannot, name the route and the change. If you could manage four flights in your office building and now stop at two, write that down. The trajectory is the primary clinical signal, and you need to communicate it clearly rather than letting the physician assume a stable baseline.

3. Bring specific language to your physician appointment. The statement “I get a little winded on stairs” will receive a different clinical response than this: “I have noticed new, progressively worsening breathlessness on exertion over the past several months. I want to rule out a cardiac cause and a pulmonary cause before attributing this to fitness. I would like an exercise stress test and spirometry.” The first statement invites a reassuring but non-specific response. The second statement identifies you as a patient who understands the differential and expects it to be addressed. If your physician dismisses the concern without a clear clinical rationale, ask directly: what makes you confident this is not ischemic in origin?

4. Ask specifically about pulmonary function testing alongside cardiac evaluation. Spirometry is a simple, inexpensive, fifteen-minute office test that measures airflow obstruction and restriction. It is not routinely ordered alongside stress testing, but it should be considered in any man with new exertional dyspnea, particularly if he has a smoking history, significant occupational dust or chemical exposure, or if the breathlessness is accompanied by cough or wheeze. Cardiac and pulmonary causes are not mutually exclusive, and treating the cardiac component while missing obstructive lung disease leaves part of the problem unaddressed.

5. Do not wait for the symptom to become severe. The default pattern for men with gradually worsening exertional dyspnea is to raise the threshold for seeking evaluation in parallel with the symptom’s progression. Two flights becomes one flight becomes the parking lot, and each new limitation gets re-attributed to the same explanation that felt adequate before. The appropriate time to be evaluated is when the symptom is new or when it is changing, not when it is disabling. Earlier evaluation means less diagnostic complexity, more treatment options, and in the case of ischemic disease, prevention of the acute events that can occur when a high-grade stenosis meets a sufficient demand. The stairs are telling you something now. The time to listen is now.

Shortness of breath climbing stairs is not always cardiac. But it is never a diagnosis of deconditioning until the cardiac and pulmonary explanations have been specifically considered and addressed. The man who avoids the stairs and waits for things to calm down is not making a neutral decision. He is making a clinical one, and he is making it without the data to support it.